January 28, 2026 12:43 PM
NDCT amendments to reduce drug development timelines, boost pharma innovation
The Union Ministry of Health and Family Welfare notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019, on Wednesday. These amendments will reduce drug development timelines and strengthen the clinical research and pharmaceutical development ecosystem. The amendments aim to simplify regulatory processes, reduce approval timelines, and promote ease of doing business. The regulatory reforms will provide substantial benefits to stakeholders while ensuring public health an...